Literature DB >> 23994771

PLA2R1 kills cancer cells by inducing mitochondrial stress.

Arnaud Augert1, David Vindrieux2, Christophe A Girard3, Benjamin Le Calvé2, Baptiste Gras2, Mylène Ferrand2, Benjamin P Bouchet2, Alain Puisieux2, Yvan de Launoit4, Hélène Simonnet2, Gérard Lambeau3, David Bernard5.   

Abstract

Little is known about the biological functions of the phospholipase A2 receptor (PLA2R1) except that it has the ability to bind a few secreted phospholipases A2 (sPLA2's). We have previously shown that PLA2R1 regulates senescence in normal human cells. In this study, we investigated the ability of PLA2R1 to control cancer cell growth. Analysis of expression in cancer cells indicates a marked PLA2R1 decrease in breast cancer cell lines compared to normal or nontransformed human mammary epithelial cells. Accordingly, PLA2R1 ectopic expression in PLA2R1-negative breast cancer cell lines led to apoptosis, whereas a prosenescence response was predominantly triggered in normal cells. PLA2R1 structure-function studies and the use of chemical inhibitors of sPLA2-related signaling pathways suggest that the effect of PLA2R1 is sPLA2-independent. Functional experiments demonstrate that PLA2R1 regulation of cell death is driven by a reactive oxygen species (ROS)-dependent mechanism. While screening for ROS-producing complexes involved in PLA2R1 biological responses, we identified a critical role for the mitochondrial electron transport chain in PLA2R1-induced ROS production and cell death. Taken together, this set of data provides evidence for an important role of PLA2R1 in controlling cancer cell death by influencing mitochondrial biology.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell death; Free radicals; Mitochondria; PLA2R1; ROS; Senescence

Mesh:

Substances:

Year:  2013        PMID: 23994771     DOI: 10.1016/j.freeradbiomed.2013.08.177

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  14 in total

1.  The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action.

Authors:  A Griveau; G Devailly; L Eberst; N Navaratnam; B Le Calvé; M Ferrand; P Faull; A Augert; R Dante; J M Vanacker; D Vindrieux; D Bernard
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

2.  A new era of secreted phospholipase A₂.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshimi Miki; Kei Yamamoto; Yoshitaka Taketomi
Journal:  J Lipid Res       Date:  2015-03-24       Impact factor: 5.922

3.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

4.  Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.

Authors:  Barbara Seitz-Polski; Guillaume Dolla; Christine Payré; Christophe A Girard; Joel Polidori; Kevin Zorzi; Eléonore Birgy-Barelli; Perrine Jullien; Cécile Courivaud; Thierry Krummel; Sylvia Benzaken; Ghislaine Bernard; Stéphane Burtey; Christophe Mariat; Vincent L M Esnault; Gérard Lambeau
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 5.  PLA2R and THSD7A: Disparate Paths to the Same Disease?

Authors:  Laurence H Beck
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

6.  Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.

Authors:  N D Quach; J N Mock; N E Scholpa; M W Eggert; C Payré; G Lambeau; R D Arnold; B S Cummings
Journal:  Mol Pharm       Date:  2014-09-22       Impact factor: 4.939

7.  Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo.

Authors:  Markus Friedemann; Brit Nacke; Albert Hagelgans; Carsten Jandeck; Nicole Bechmann; Martin Ullrich; Birgit Belter; Christin Neuber; Olga Sukocheva; Jens Pietzsch; Mario Menschikowski
Journal:  Oncotarget       Date:  2018-11-13

8.  Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.

Authors:  Audrey Griveau; Clotilde Wiel; Benjamin Le Calvé; Dorian V Ziegler; Sophia Djebali; Marine Warnier; Nadine Martin; Jacqueline Marvel; David Vindrieux; Martin O Bergo; David Bernard
Journal:  Aging Cell       Date:  2018-09-14       Impact factor: 9.304

9.  Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Brit Nacke; Carsten Jandeck; Olga Sukocheva; Gabriele Siegert
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

10.  Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth.

Authors:  David Vindrieux; Guillaume Devailly; Arnaud Augert; Benjamin Le Calvé; Mylène Ferrand; Pascal Pigny; Léa Payen; Gérard Lambeau; Michael Perrais; Sébastien Aubert; Hélène Simonnet; Robert Dante; David Bernard
Journal:  Oncotarget       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.